J Neurochem 70:26132619 Kunnecke B, Cerdan S, Seelig J (1993) Cerebral metabolism of [1,2-13C2]glucose and [U-13C4]3-hydroxybutyrate in rat brain as detected by 13 C NMR spectroscopy
Safer Alternatives and Evidence-Based Treatment Options MHRA-licensed options including semaglutide (Wegovy), liraglutide (Saxenda), orlistat, and tirzepatide (Mounjaro) offer evidence-based weight management with well-characterised safety profiles and defined NICE eligibility criteria
At this dose, appetite suppression is typically significant
Some patients have reported subjective experiences of altered sleep patterns whilst taking Saxenda, though there is no established pharmacological mechanism by which liraglutide would directly interfere with sleep-wake cycles or cause insomnia
You can always increase later if you want to
View All Images This lady in her 30s had 5 children, 3 via C-section